[FATE] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
09-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- -8.80%
YoY- -423.49%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 1,925 58,980 18,414 11,142 2,515 2,632 1,026 11.04%
PBT -48,004 -18,881 -65,690 -45,089 -33,520 -19,760 -14,135 22.57%
Tax 4,778 -9,711 -8,777 -1,121 0 1,091 331 55.97%
NP -48,004 -9,170 -56,913 -45,089 -33,520 -19,760 -14,135 22.57%
Tax Rate - - - - - - - -
Total Cost 49,929 68,150 75,327 56,231 36,035 22,392 15,161 21.95%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -2,493.71 -15.55 -309.07 -404.68 -1,332.80 -750.76 -1,377.68 10.38%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.47 -0.09 -0.59 -0.48 -0.44 -0.30 -0.27 9.66%
EPS Diluted -0.47 -0.09 -0.59 -0.48 -0.44 -0.30 -0.27 9.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.